Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-19 @ 3:50 PM
Study NCT ID:
NCT00189956
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2005-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Sponsor:
Bavarian Nordic
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
POX-MVA-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |